SUBCLINICAL HYPOTHYROIDISM IN PREGNANCY; IS THERE A NEED FOR PHARMACOLOGICAL INTERVENTION?
Objective: To find the prevalence of subclinical hypothyroidism in the first trimester of pregnancy and to compare the maternal and perinatal outcome in them with euthyroid mothers.
Methods: The present study was a prospective observational case-control study done in a tertiary hospital over the period of one and half years. Pregnant women in the first trimester of pregnancy were tested for Thyroid Stimulating Hormone (TSH) levels and those who had TSH>2.5mIU/l, free T3 and free T4 estimation was carried out on the same sample. A total of 171 women could be followed up till delivery and their first-trimester thyroid profile was available for analysis. They were grouped into two groups, Group 1: all women with TSH level>2.5 mIU/l, considered to be hypothyroid (n=79), Group 2: women with euthyroid status with TSH levels 0.1 to 2.5 mIU/l (n=95). All the neonates delivered in the first group had cord blood TSH estimation.
Results: In the study period, there were 2632 deliveries. The number of pregnant women with first trimester TSH levels>2.5 mIU/l were 79, giving the prevalence rate of 3 % for subclinical hypothyroidism during pregnancy. The obstetric complications observed were gestational hypertension 3.8%, gestational diabetes 6.3%, placenta praevia1.3% and preterm delivery 7.6%. The perinatal complications included Intrauterine growth restriction (IUGR) 1.3%, Low Birth Weight (LBW) 3.8%, perinatal asphyxia 2.5% and neonatal hypothyroidism 1.3%. Only preterm delivery appeared to be significantly associated with subclinical hypothyroidism.
Conclusion: The observed complication rates were much similar, in fact, lesser with gestational diabetes, pregnancy hypertension, IUGR, LBW compared to global and Indian prevalence rates. This indicates that the cut-off for diagnosing subclinical hypothyroidism should be derived from TSH assays from the local geographic population and should guide the treating physician to establish appropriate TSH ranges where definite therapeutic intervention is required to improve the maternal and foetal outcome.
2. Mannisto T, Vaarasmaki M, Hartikainen AL. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 2009;94:772-9.
3. So LB, Mandel SJ. Thyroid disorders during pregnancy. Endocrinol Metabol Clin North Am 2006;35:117-36.
4. Smallridge RC, Glinoer D, Hallowell JG, Brent G. Thyroid function inside and outside pregnancy: what do we know and what donâ€™t we know? Thyroid 2005;15:54.
5. Sanghvi U, Diwakar KK. Universal newborn screening for congenital hypothyroidism. Indian Pediatr 2008;45:331-2.
6. PÃ¤kkilÃ¤ F, MÃ¤nnistÃ¶ T, Hartikainen AL. Maternal and child's thyroid function and child's intellect and scholastic performance. Thyroid 2015;25:1363-74.
7. Stagnaro-green A, Abalovich M, Alexander E. Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-125.
8. Zarghami N, Rohbani-noubar M, Khosrowbeygi A. Thyroid hormones status during pregnancy in normal Iranian women. Indian J Clin Biochem 2005;20:182-5.
9. Yussuf AY, Bhogireddy N, Vulli V, Verma A, Bhaskaran AA. Thyroid stimulating hormones and free thyroxine as an indication of thyroid dysfunction at pathology laboratory of Mnazi Mmoja Hospital, Zanzibar. Asian J Pharm Clin Res 2014:7;67-71.
10. Marwaha RK, Tandon N, Gupta N, Karak AK, Verma K, Kochupillai N. Residual goitre in the post-ionization phase: Iodine status, thiocyanate exposure and autoimmunity. Clin Endocrinol (Oxf) 2003;59:672-81.
11. Das S, Bhansali A, Dutta P, Aggarwal A, Bansal MP, Garg D, et al. Persistence of goitre in the post-iodization phase: micronutrient deficiency or thyroid autoimmunity? Indian J Med Res 2011;133:103-9.
12. Glinoer D, de-Nayer P, Bourdoux P. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990;71:276-87.
13. Ballabio M, Poshyachinda M, Ekins RP. Pregnancy-induced changes in thyroid function: the role of human chorionic gonadotropin as a putative regulator of the maternal thyroid. J Clin Endocrinol Metab 1991;73:824-31.
14. WHO, UNICEF. Reaching optimal iodine nutrition in pregnant and lactating women and young children: a joint statement by WHO and UNICEF. Geneva, World Health Organization; 2007.
15. Reid SM, Middleton P, Cossich MC, Crowther CA, Bain E. Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy. Cochrane Database Syst Rev 2013;CD007752.
16. Blencowe H, Cousens S, Chou D. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013;10 Suppl 1:S2.
17. Gupte S, Wagh G. Preeclampsia-eclampsia. J Obstet Gynaecol India 2014;64:4-13.
18. Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India 2004;52:707-11.
19. Kalaivani K. Prevalence and consequences of anaemia in pregnancy. Indian J Med Res 2009;130:627-33.
20. Hebbar SS, Rai L, Zainab R, Guruvare S, Adiga P, Mundkur A. Influence of placental position on obstetric morbidity in placenta praevia. Int J Reprod Contracept Obstet Gynecol 2014;3:585-91.
21. Pillay P, Janaki S, Manjila C. A Comparative study of gravedo gram and ultrasound in the detection of IUGR. J Obstet Gynaecol India 2012;62:409-12.
22. Bharati P, Pal M, Bandyopadhyay M, Bhakta A, Chakraborty S, Bharati P. Prevalence and causes of low birth weight in India. Malays J Nutr 2011;17:301-13.
23. Babu BVA, Devi SS, Kumar BK. Birth asphyxia,-Incidence and immediate outcome in relation to risk factors and complications. Int J Res Health Sci 2014;2:1064-71.
24. Li C, Shan Z, Mao J. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab 2014;99:73-9.
25. Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanwar RS, Sastry A, et al. Establishment of erence range for thyroid hormones in normal pregnant Indian women. Br J Obstet Gynaecol 2008;115:602-6.
26. Casey BM, Dashe JS, Spong CY. The perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007;109:1129-35.
27. Cotzias C, Wong SJ, Taylor E. A study to establish gestation-specific erence intervals for thyroid function tests in a normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol 2008;137:61-6.
28. Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. Br Med J 2014;349:g4929.
29. Ajmani SN, Aggarwal D, Bhatia P, Sharma M, Sarabhai V, Paul M. Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on the maternal and fetal outcome. J Obstet Gynaecol India 2014;64:105-10.
30. Aggarwal N, Suri V, Joshi B, Dutta P, Bhansali A, Mukhopadhyay. Prevalence and impact of subclinical hypothyroidism in the pregnancy-prospective study from apex institute of North India. Med Sci 2014;4:404-6.
31. Pavanaganga A, Rekha BR, Sailakshmi MPA, Nagaratnamma. An observational study of subclinical hypothyroidism in pregnancy. Indian J Obstetrics Gynaecol Res 2015;2:255-60.
32. Singh A, Reddy MJ. Prevalence of thyroid dysfunction in pregnancy and its implications. Int J Med Sci Public Health 2015;4:1247-50.
33. Kalpesh K, Alpesh P, Harshid LP. High prevalence of thyroid dysfunction among pregnant women in Ahmedabad City, Gujarat, India. Int J Adv Res 2015;3:676-82.
34. Nirmala C, Jayakumari C, Rajasekharan C, Nandini VR. Maternal outcome of hypothyroidism in pregnancy-a south Indian perspective. Am J Clin Med Res 2014;2:47-50.
35. Sreelakshmi U, Divya JT. Evaluation of effects of subclinical hypothyroidism in pregnancy and its outcome. Int J Sci Res 2015;4:1534-7.
36. Nath J, Duta S. A clinical study on thyroid dysfunction in pregnancy and its effect on the foetomaternal outcome. Int J Sci Res 2015;4:2068-70.
37. Saraladevi R, Nirmala Kumari T, Shreen B, Usha Rani V. Prevalence of thyroid disorder in pregnancy and pregnancy outcome. Int Arch Integrated Med 2016;3:1-11.
38. Patwari M, Talukdar B, Waanbah BD. Study of thyroid profile in pregnancy with perinatal outcome. New Indian J Obgyn 2016;2:73-7.
39. Chunchaiah S, Prasad N, Murali BM, Rupakala BM, Rangaiah N. A prospective observational study of thyroid dysfunctions during pregnancy in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol 2016;5:3683-9.
40. Patel RD, Deliwala KJ, Shah PT, Singh RK. The fetomaternal outcome of thyroid disorder in pregnancy. Int J Reprod Contracept Obstet Gynecol 2016;5:4466-9.
41. Rajalakshmi MS, Singh AK, Sujit D, Samchetsabam RD. The fetomaternal outcome in maternal hypothyroidism complicating pregnancies at RIMS: a prospective study. Eur J Pharm Med Res 2016;3:452-9.
42. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012;366:493-501.
43. Gupta G, Sharma P, Kumar P, Sharma R. Scope of inflammatory markers in subclinical hypothyroidism. Asian J Pharm Clin Res 2015;8;24-7.
44. National Guidelines for Screening of Hypothyroidism during Pregnancy, Ministry of Health and Family Welfare, Government of India; 2014.